According to Nektar Therapeutics 's latest financial reports the company's current earnings are HK$93.13 Million. In 2023 the company made an earning of -HK$2.15 Billion, an increase over its 2022 earnings that were of -HK$2.84 Billion. The earnings displayed on this page is the company's Pretax Income.